FARMACIA Y TECNOLOGÍA FARMACÉUTICA
Departamento
Universidad Complutense de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Complutense de Madrid (45)
2019
-
A comparative analysis of the pharmacovigilance systems of Brazil, Spain, the European Union and the United States based on the information provided by their regulatory agency websites
DARU, Journal of Pharmaceutical Sciences, Vol. 27, Núm. 1, pp. 379-387
2016
-
Vascular and central activation of peroxisome proliferator-activated receptor-β attenuates angiotensin II-induced hypertension: Role of RGS-5
Journal of Pharmacology and Experimental Therapeutics, Vol. 358, Núm. 1, pp. 151-163
2015
-
Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity
Journal of Hypertension, Vol. 33, Núm. 9, pp. 1831-1844
2014
-
Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus
Hypertension, Vol. 64, Núm. 2, pp. 330-337
-
Implementing smart pump technology in a pediatric intensive care unit: A cost-effective approach
International Journal of Medical Informatics, Vol. 83, Núm. 2, pp. 99-105
-
PPARβ activation restores the high glucose-induced impairment of insulin signalling in endothelial cells
British Journal of Pharmacology, Vol. 171, Núm. 12, pp. 3089-3102
2013
-
Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension
Cardiovascular Research, Vol. 99, Núm. 4, pp. 622-631
-
Impact of implementing smart infusion pumps in a pediatric intensive care unit
American Journal of Health-System Pharmacy, Vol. 70, Núm. 21, pp. 1897-1906
-
SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: Implications for vascular aging
Biochemical Pharmacology, Vol. 85, Núm. 9, pp. 1288-1296
2012
-
Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats
Free Radical Biology and Medicine, Vol. 53, Núm. 4, pp. 730-741
-
Different cardiovascular protective effects of quercetin administered orally or intraperitoneally in spontaneously hypertensive rats
Food and Function, Vol. 3, Núm. 6, pp. 643-650
-
Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension
Free Radical Biology and Medicine, Vol. 52, Núm. 1, pp. 70-79
2011
-
Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats
Hypertension, Vol. 58, Núm. 4, pp. 733-743
-
Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats
British Journal of Nutrition, Vol. 106, Núm. 9, pp. 1337-1348
-
Red wine polyphenols prevent endothelial dysfunction induced by endothelin-1 in rat aorta: Role of NADPH oxidase
Clinical Science, Vol. 120, Núm. 8, pp. 321-333
-
Vascular deconjugation of quercetin glucuronide: The flavonoid paradox revealed?
Molecular Nutrition and Food Research, Vol. 55, Núm. 12, pp. 1780-1790
2010
-
Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor β agonists via the phosphatidyl-inositol-3 kinase-Akt pathway
Journal of Pharmacology and Experimental Therapeutics, Vol. 332, Núm. 2, pp. 554-561
-
Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats
European Journal of Pharmacology, Vol. 627, Núm. 1-3, pp. 242-250
-
Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation
Atherosclerosis, Vol. 212, Núm. 1, pp. 78-85
2009
-
Efficient Horner-Wadsworth-Emmons intramolecular cyclisation of a N-substituted phthalimide promoted by KF-Alumina: a general tool for the synthesis of functionalised isoindolinones
Tetrahedron Letters, Vol. 50, Núm. 25, pp. 3050-3053